Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 463 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR FDA Grants Accelerated Approval to Infigratinib for Metastatic Cholangiocarcinoma June 2, 2021 FDA Approves Alpelisib for PIK3CA-Related Overgrowth Spectrum April 13, 2022 Self-care Isn’t Selfish August 25, 2021 Neoadjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy Can Be Delivered Safely in Patients with Operable... January 26, 2023 Load more HOT NEWS Tackling under-representation of Black data scientists in cancer research Breastfeeding Patterns and Relation to Breast Cancer Outcomes After Early, Hormone... The Barriers to Care Faced by LGBTQ People With Cancer: An... FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer
